MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jgar.2020.09.005

Медицинская библиотека · Journal of global antimicrobial resistance · 2020

Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major.

Navard Sahar Hamoon, Rezvan Hossein, Haddad Mohammad Hossein Feiz, Ali S A, Nourian Alireza, Eslaminejad Mohamadreza Baghaban, Behmanesh Mohammad Amin

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

OBJECTIVES

Leishmania major (L. major) is a cutaneous leishmaniasis causative agent. Current chemotherapeutic methods are not totally effective in treatment of this disease. The immunomodulation and tissue repairing capability of mesenchymal stem cells (MSCs), ease of isolation, detection and in vitro culture, have encouraged biologists to use MSCs for cell therapy in different infections such as cutaneous leishmaniasis.

METHODS

BALB/c mice (6-8 weeks old) were infected with L. major then divided into four groups and treated with MSCs, Glucantime, Glucantime + MSCs, or PBS. Regression of lesions, potency of macrophages for phagocytosis, proliferation of immune cells against Leishmania soluble antigen, reduction of spleen parasite burden and healing of the lesions were evaluated on days 10, 20 and 30 of treatment.

RESULTS

The results indicated that the mice intralesionally injected with MSCs showed significant regression in the lesions produced by L. major by day 30. Proliferation of splenocytes stimulated with SLA (soluble leishmania antigen) in vitro in MSC-treated mice on day 20 was significantly higher than in the other groups. The potency of phagocytosis in macrophages of mice treated with MSCs was significantly higher by day 30 and healing of the lesions in this group of mice showed more progress on histopathological examinations. Spleen parasite burden showed significant reduction in the mice treated with Glucantime + MSCs by day 30.

CONCLUSIONS

The results showed that including MSCs in treatment of cutaneous leishmaniasis caused by L. major is a promising approach.

Для цитирования: Navard Sahar Hamoon, Rezvan Hossein, Haddad Mohammad Hossein Feiz, Ali S A, Nourian Alireza, Eslaminejad Mohamadreza Baghaban, Behmanesh Mohammad Amin. Therapeutic effects of mesenchymal stem cells on cutaneous leishmaniasis lesions caused by Leishmania major.. Journal of global antimicrobial resistance. 2020. DOI: 10.1016/j.jgar.2020.09.005.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.